Halozyme Therapeutics, Inc. (LON:0J2O)

Halozyme Therapeutics Statistics

Total Valuation

LON:0J2O has a market cap or net worth of GBP 6.01 billion. The enterprise value is 6.63 billion.

Market Cap	6.01B
Enterprise Value	6.63B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	117.60M
Shares Outstanding	n/a
Shares Change (YoY)	-3.31%
Shares Change (QoQ)	-1.47%
Owned by Insiders (%)	1.10%
Owned by Institutions (%)	103.95%
Float	116.20M

Valuation Ratios

The trailing PE ratio is 13.57 and the forward PE ratio is 9.10.

PE Ratio	13.57
Forward PE	9.10
PS Ratio	6.50
PB Ratio	16.04
P/TBV Ratio	n/a
P/FCF Ratio	13.41
P/OCF Ratio	13.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 14.80.

EV / Earnings	14.97
EV / Sales	7.20
EV / EBITDA	10.88
EV / EBIT	12.13
EV / FCF	14.80

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 3.05.

Current Ratio	1.59
Quick Ratio	1.25
Debt / Equity	3.05
Debt / EBITDA	1.87
Debt / FCF	2.55
Interest Coverage	41.53

Financial Efficiency

Return on equity (ROE) is 124.50% and return on invested capital (ROIC) is 22.87%.

Return on Equity (ROE)	124.50%
Return on Assets (ROA)	21.24%
Return on Invested Capital (ROIC)	22.87%
Return on Capital Employed (ROCE)	53.28%
Revenue Per Employee	2.64M
Profits Per Employee	1.27M
Employee Count	350
Asset Turnover	0.57
Inventory Turnover	1.65

Taxes

In the past 12 months, LON:0J2O has paid 111.92 million in taxes.

Income Tax	111.92M
Effective Tax Rate	20.17%

Stock Price Statistics

The stock price has increased by +43.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+43.33%
50-Day Moving Average	67.40
200-Day Moving Average	63.56
Relative Strength Index (RSI)	60.21
Average Volume (20 Days)	2,417

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.50

Income Statement

In the last 12 months, LON:0J2O had revenue of GBP 924.61 million and earned 443.01 million in profits. Earnings per share was 3.52.

Revenue	924.61M
Gross Profit	729.63M
Operating Income	548.58M
Pretax Income	554.93M
Net Income	443.01M
EBITDA	605.03M
EBIT	548.58M
Earnings Per Share (EPS)	3.52

Balance Sheet

The company has 522.22 million in cash and 1.14 billion in debt, giving a net cash position of -622.60 million.

Cash & Cash Equivalents	522.22M
Total Debt	1.14B
Net Cash	-622.60M
Net Cash Per Share	n/a
Equity (Book Value)	374.88M
Book Value Per Share	3.19
Working Capital	365.66M

Cash Flow

In the last 12 months, operating cash flow was 454.54 million and capital expenditures -6.39 million, giving a free cash flow of 448.15 million.

Operating Cash Flow	454.54M
Capital Expenditures	-6.39M
Free Cash Flow	448.15M
FCF Per Share	n/a

Margins

Gross margin is 78.91%, with operating and profit margins of 59.33% and 47.91%.

Gross Margin	78.91%
Operating Margin	59.33%
Pretax Margin	60.02%
Profit Margin	47.91%
EBITDA Margin	65.44%
EBIT Margin	59.33%
FCF Margin	48.47%

Dividends & Yields

LON:0J2O does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.31%
Shareholder Yield	3.31%
Earnings Yield	7.37%
FCF Yield	7.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0J2O has an Altman Z-Score of 4.74 and a Piotroski F-Score of 7.

Altman Z-Score	4.74
Piotroski F-Score	7